8-K filing — Clene Inc. (CLNN)
Filed: 2026-09-16 AccNo: 0001437749-26-030581 Size: 430 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Clene Prices Registered Direct Offering Of 1,219,513 Shares At $3.28/Shr To Existing Shareholders With Total Gross Proceeds Of $4M
Investment led by Clene’s Chairman of the Board of Directors, alongside founding investor Kensington Capital Holdings, Clene’s Chief Executive Officer and other existing shareholders$4 million registered direct offering
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Clene shares are trading higher after the company announced the pricing of a registered direct offering of 1,219,513 shares at $3.28 per share to existing shareholders with total gross proceeds of $4 million.
Clene Says Post Hoc Analyses Show CNM-Au8-Treated ALS Patients With NfL Decline Or Stabilization Had 38% Lower Risk Of Death vs. Controls In HEALEY; NDA Planned For Early Q4